Justin Bone detailed the days leading up to his arrest, describing taking drugs and wandering various parts of the city after being dropped off by RCMP.
Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two experimental ...
With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related ...
Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in ...
For more than a century, Alzheimer’s disease has been considered a condition that cannot be reversed. Doctors have focused on slowing the disease because they believed the damage to brain cells could ...
A drug that raises levels of histamine – the chemical that causes allergy symptoms – in the brain boosts our memory by around ...
People with Alzheimer’s disease who took the common supplement glucosamine were 25% more likely to die within five years than ...
Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their ...
Ambitious studies have been examining the protective effects of diet, exercise and socializing — with surprising results.
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of ...
Health chiefs have been accused of exaggerating the cost of administering breakthrough Alzheimer’s drugs, resulting in their rollout being blocked.
Alzheimer’s is not easy. But with the right information, support and mindset, it is still possible for Californians to face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results